We are live on ! Find out more
CCA

Clearwater Capital Advisors Portfolio holdings

AUM $1.36B
1-Year Est. Return 18.79%
This Fund
S&P 500
This Quarter Est. Return
+3.16%
1 Year Est. Return
+18.79%
3 Year Est. Return
+44.71%
5 Year Est. Return
+37.12%
10 Year Est. Return
+112.13%
AUM
$800M
AUM Growth
+$46.2M
Cap. Flow
+$27.3M
Cap. Flow %
3.41%
Top 10 Hldgs %
50.08%
Holding
171
New
17
Increased
35
Reduced
99
Closed
11
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPN icon
126
Global Payments
GPN
$23.6B
$307K 0.04%
+1,521
New +$303K
IDU icon
127
iShares US Utilities ETF
IDU
$1.39B
$306K 0.04%
3,840
-750
-16% -$57.7K
PEY icon
128
Invesco High Yield Equity Dividend Achievers ETF
PEY
$1.16B
$306K 0.04%
15,123
-1,193
-7% -$22.5K
SPHQ icon
129
Invesco S&P 500 Quality ETF
SPHQ
$19.8B
$293K 0.04%
6,600
-205
-3% -$8.85K
BX icon
130
Blackstone
BX
$107B
$291K 0.04%
+3,900
New +$269K
PHO icon
131
Invesco Water Resources ETF
PHO
$2.07B
$290K 0.04%
5,880
-510
-8% -$24.7K
CSCO icon
132
Cisco
CSCO
$477B
$288K 0.04%
5,579
-8
-0.1% -$376
IYW icon
133
iShares US Technology ETF
IYW
$24.9B
$288K 0.04%
3,279
IVW icon
134
iShares S&P 500 Growth ETF
IVW
$77.2B
$279K 0.03%
4,289
-463
-10% -$29.9K
IJK icon
135
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.1B
$277K 0.03%
3,531
-687
-16% -$52.9K
IYF icon
136
iShares US Financials ETF
IYF
$4.61B
$277K 0.03%
3,703
-121
-3% -$8.6K
CRSP icon
137
CRISPR Therapeutics
CRSP
$5.05B
$269K 0.03%
2,211
+863
+64% +$130K
TDOC icon
138
Teladoc Health
TDOC
$1.22B
$268K 0.03%
1,476
+297
+25% +$68.9K
POTX
139
DELISTED
Global X Cannabis ETF
POTX
$268K 0.03%
2,783
+616
+28% +$61.1K
META icon
140
Meta Platforms (Facebook)
META
$1.5T
$265K 0.03%
899
GOOGL icon
141
Alphabet (Google) Class A
GOOGL
$4.37T
$260K 0.03%
+2,520
New +$249K
PRF icon
142
Invesco FTSE RAFI US 1000 ETF
PRF
$9.96B
$258K 0.03%
8,520
-2,190
-20% -$62.9K
VYM icon
143
Vanguard High Dividend Yield ETF
VYM
$82.4B
$256K 0.03%
2,537
-271
-10% -$26.1K
VO icon
144
Vanguard Morningstar Mid-Cap ETF
VO
$108B
$251K 0.03%
4,540
-492
-10% -$26.7K
IMCB icon
145
iShares Morningstar Mid-Cap ETF
IMCB
$1.69B
$249K 0.03%
3,956
-244
-6% -$14.9K
LLY icon
146
Eli Lilly
LLY
$1.05T
$248K 0.03%
1,325
DVY icon
147
iShares Select Dividend ETF
DVY
$23.5B
$246K 0.03%
2,155
-223
-9% -$23.6K
PACB icon
148
Pacific Biosciences
PACB
$379M
$246K 0.03%
+7,394
New +$259K
GOOG icon
149
Alphabet (Google) Class C
GOOG
$4.36T
$244K 0.03%
2,360
SRCL
150
DELISTED
Stericycle Inc
SRCL
$243K 0.03%
3,593

Similar funds

Clearwater Capital Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, Clearwater Capital Advisors held 171 positions worth $800M, up 6.1% from $754M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Clearwater Capital Advisors deployed $27.3M of net new capital in Q1 2021, opening 17 new positions and adding to 35 existing holdings. Its largest new stake was State Street SPDR Bloomberg Emerging Markets Local Bond ETF: 1,339,268 shares worth $34.8M.

By sector, the portfolio is most concentrated in Technology at 1.3% of assets, up from 1.3% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Schwab US Aggregate Bond ETF, an estimated $13.8M trimmed.

  • Clearwater Capital Advisors's largest Q1 2021 buy was State Street SPDR Bloomberg Emerging Markets Local Bond ETF: 1,339,268 shares worth $34.8M.
  • Clearwater Capital Advisors added most to iShares 0-5 Year High Yield Corporate Bond ETF in Q1 2021, an estimated $5.33M increase.
  • Clearwater Capital Advisors's biggest Q1 2021 reduction was Schwab US Aggregate Bond ETF, cutting an estimated $13.8M.
  • Clearwater Capital Advisors fully exited iShares Ultra Short Duration Bond Active ETF in Q1 2021, selling an estimated $35.5M.
  • Clearwater Capital Advisors's ten largest holdings make up 50% of its $800M portfolio in Q1 2021.
  • Clearwater Capital Advisors opened 17 new positions and closed 11 in Q1 2021.
  • Clearwater Capital Advisors's portfolio value rose 6.1% quarter-over-quarter to $800M.

Based on Clearwater Capital Advisors's 13F filing for Q1 2021, filed 21 Apr 2021.